Page last updated: 2024-08-23

fialuridine and Adenocarcinoma

fialuridine has been researched along with Adenocarcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heo, K; Kang, SH; Kim, D; Kim, EO; Kim, H; Kim, IH; Kim, KT; Kim, SK; Kim, YH; Koh, SS; Lee, SJ; Lee, SW; Lee, Y; Moon, JY; Song, MS1
Blasberg, R; Burgman, P; Cai, S; Finn, R; Gelovani, J; Li, GC; Ling, CC; O'donoghue, J; Serganova, I; Wen, B; Zanzonico, P1

Other Studies

2 other study(ies) available for fialuridine and Adenocarcinoma

ArticleYear
Efficient targeting and tumor retardation effect of pancreatic adenocarcinoma up-regulated factor (PAUF)-specific RNA replacement in pancreatic cancer mouse model.
    Cancer letters, 2014, Mar-28, Volume: 344, Issue:2

    Topics: Adenocarcinoma; Adenoviridae; Animals; Arabinofuranosyluracil; Cell Line, Tumor; Female; Genetic Therapy; Humans; Intercellular Signaling Peptides and Proteins; Iodine Radioisotopes; Lectins; Mice; Mice, Inbred BALB C; Pancreatic Neoplasms; Random Allocation; RNA; RNA, Catalytic; Thymidine Kinase; Tomography, Emission-Computed, Single-Photon; Transgenes; Xenograft Model Antitumor Assays

2014
A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia.
    European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:11

    Topics: Adenocarcinoma; Animals; Arabinofuranosyluracil; Biomarkers, Tumor; Cell Hypoxia; Cell Line, Tumor; Disease Models, Animal; DNA-Binding Proteins; Drug Evaluation, Preclinical; Feasibility Studies; Fluorine Radioisotopes; Gene Expression Profiling; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Iodine Radioisotopes; Misonidazole; Nuclear Proteins; Radionuclide Imaging; Radiopharmaceuticals; Rats; Thymidine Kinase; Transcription Factors; Viral Proteins

2004